Submit Manuscript now
Impact Factor 2.6

Volume 8

Primary Biliary Cholangitis and Type 1 Diabetes in A Male Patient: A Case Report

Leave a Comment / Issue 1 Articles, Volume 8 / By

1. Abstract Primary Biliary Cholangitis (PBC) isa cholestatic disease of autoimmune origin characterized by the destruction of small to medium size intrahepatic bile ducts due to lymphocytic infiltration. The diagnosis is made by the presence of Anti-Mitochondrial Antibodies (AMAs) specific for the disease. PBC typically affects middle-aged women and is often associated with other autoimmune …

Primary Biliary Cholangitis and Type 1 Diabetes in A Male Patient: A Case Report Read More »

Pseudotumoral Form of Primary Hepatic Tuberculosis: A Rare Case Report with Review of the Literature

Leave a Comment / Issue 1 Articles, Volume 8 / By

1. Abstract The isolated location of tuberculosis is very rare constituting less than 1% of all locations. We report through this observation the case of a 23-year-old patient, who complains of chronic pain in the right hypochondrium in a context of deterioration of the general condition. The biological assessment showed a biological inflammatory syndrome. A …

Pseudotumoral Form of Primary Hepatic Tuberculosis: A Rare Case Report with Review of the Literature Read More »

Comparing The Efficacy and Safety of Local-Regional Treatments for Hepatocellular Carcinoma with Portal/Hepatic Vein Tumor Thrombosis in China: A Network Meta-Analysis of Randomized Control Trials

Leave a Comment / Issue 1 Articles, Volume 8 / By

1. Abstract 1.1. Purpose: We assessed the efficacy and safety of different local-regional regimens using the network metaanalysis for hepatocellular carcinoma (HCC) with portal/hepatic vein tumor thrombosis. The interested modalities included neoadjuvant three-dimensional radiotherapy(3D-CRT), postoperative intensity-modulated radiation therapy(IMRT), Postoperative transarterial chemoembolization (TACE), 3DCRT plus TACE, and Surgery alone.

What Our Author Say's

I am glad that I found this platform. It was easy to get my research published and I was guided at every step. I highly recommend them.
Shuang-Qin Yi
am grateful to the Japanese Journal of Gastroenterology and Hepatology for helping me with my research and publishing it. Looking forward to more work with them.
Makki Fayadh
It has been a pleasure working with the Japanese Journal of Gastroenterology and Hepatology. They have been amazing in helping me with my manuscript
Han Min
I am glad that I submitted my manuscript here. They helped me make necessary edits and published the best version of it. I highly recommend them.
Sadaf Saleem

FAQ's About Jajgastrohepto

The Japanese Journal of Gastroenterology and Hepatology accepts all kinds of manuscripts, such as research, studies, reviews, clinical images, editorials, commentaries, etc.

For Detailed quotations reach out submission@jajogh.jp

It depends on the length of the manuscript and the reviews and edits needed.

We will help you with as many reviews and edits as are required to make your manuscript perfect for publication.

A good impact factor for JJGH is 2.0 as per Journal Citations Reports of 2021.

Niigata, 7F Stork Building Kagamibashi, 1230-7, 7-bancho, Kamiookawamaedori, Chuo-ku, Niigata, 951-8068, Japan.

*2021 Journal unofficial Impact Factor was established by dividing the number of articles published in 2020 with the number of times they are cited in 2021 based on Google Scholar Citation Index database. If ‘X’ is the total number of articles published in 2020 and ‘Y’ is the number of times these articles were cited in indexed journals during 2021 then, journal impact factor = Y/X.

Copyright 2018-2024 All Rights Reserved.